Recognition of specific antigen through the B-cell receptor (BCR) stimulates the activation of B cells, which ultimately results in the production of high-affinity antibodies and the provision of ...

Such a vaccine would have to stimulate B cells that have receptors (which then become antibodies) that target those shared, or "conserved," regions. When B cells circulating in the body encounter a ...

Antibodies against B cells Rituximab is a depleting antibody ... Tocilizumab is a monoclonal antibody directed against the IL-6 receptor that has established benefit in RA both with regards ...